Financials data is unavailable for this security.
View more
Year on year Venus Remedies Ltd grew revenues 8.27% from 5.56bn to 6.01bn while net income improved 7.25% from 265.66m to 284.91m.
| Gross margin | 40.74% |
|---|---|
| Net profit margin | 4.64% |
| Operating margin | 5.79% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Venus Remedies Ltd increased its cash reserves by 130.79%, or 277.44m. The company earned 372.85m from its operations for a Cash Flow Margin of 6.20%. In addition the company used 72.09m on investing activities and also paid 10.83m in financing cash flows.
| Cash flow per share | 40.06 |
|---|---|
| Price/Cash flow per share | 8.60 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
